Triumvira Immunologics Appoints Scott Smith to Board of Directors
Innovative immuno-therapy company welcomes former President and COO of Celgene AUSTIN, Texas & TORONTO–(BUSINESS WIRE)–Triumvira Immunologics, Inc., a privately held biopharmaceutical company developing a novel platform for engineering T cells to...Read More >>